LONDON – Studies have shown that marijuana not only helps fight the symptoms of treating cancer but also the disease itself. THC, or tetrahydrocannabinol, often gets the credit for battling cancer cells, but a new study shows that THC isn’t working alone. The study conducted at St. George’s University of London, led by Dr. Wai Liu, examined six […]
Read More Anti-Cancer Properties of Medical Marijuana Revealed in its entirety on The Daily Chronic.
Want to stay up to date on marijuana reform & cannabis news worldwide? Visit The Daily Chronic - The Voice of the Reform Generation, the most comprehensive coverage of the cannabis community!
SOURCE: More Anti-Cancer Properties of Medical Marijuana Revealed by Marijuana Policy Project
. . . . . READ MOREMORGANTOWN, WV – THC possesses gastroprotective qualities and could potentially reduce incidences of NSAID (non-steroidal anti-inflammatory drugs)- induced hospitalizations, according to preclinical data published online in the European Journal of Pharmacology.
Investigators at West Virginia University assessed the impact of THC administration in an animal model of NSAID-induced gastric inflammation. They reported that low doses of THC provided gastroprotective effects, such as attenuating gastric hemorrhages and lesions, and reducing ulcers.
Researchers concluded:
“The results of the present study suggest that delta-9-THC … may also possess gastroprotective effects in NSAID using patients. … As current antacid regimens may be associated with undesirable effects, … other approaches to prevent NSAID-induced gastric ulcers are needed. In addition to their gastroprotective effects, cannabinoids produce other beneficial effects, including pain reduction. … Thus, cannabinoids may have the added benefit of reducing the effective analgesic dose of NSAIDs, as well as reducing the incidence of NSAID-induced gastric ulcers.”
NSAIDs such as ibuprofren are among the most widely used analgesic substances in the world, but their consumption is associated with v. . . . . READ MORE
MORGANTOWN, WV — Non-steroidal anti-inflammatory drugs (NSAID), such as ibuprofen, are among the most widely used analgesic substances in the world. However, the consumption of these products is associated with various adverse and life-threatening side-effects such as heart-attack, stroke, and internal bleeding.
In fact, according to a 2001 analysis, in the United States alone, “gastrointestinal complications induced by non-steroidal anti-inflammatory drugs (NSAIDs) cause more than 100,000 hospitalizations and an estimated 16,500 deaths annually.”
Could these adverse gastrointestinal effects be offset by cannabis? A just published study in the European Journal of Pharmacology indicates that the most likely answer is ‘yes.’
Researchers at West Virginia University assessed the impact of THC administration in an animal model of NSAID-induced gastric inflammation. Investigators reported that low doses of THC provided gastroprotective effects, significantly attenuating gastric hemorrhages and lesions.
They concluded: “The results of the present study suggest that delta-9-THC … may also possess gastroprotective effects in NSAID using patients. … As current antacid regimens may be associated with undesirable effects, such as reduced bone density, increased risk of bacterial infection, and vitamin deficiencies. . . . . READ MORE
PARIS, FRANCE – At the behest of Social Affairs and Health Minister Marisol Touraine, France has modified its Public Health Code to allow for the use of marijuana-based medicines, apparently including raw marijuana itself.
Decree n° 2013-473 was published Friday, removing what had been a prohibition on all non-industrial use of the plant.
The code modification makes legal “the production, transport, export, possession, offering, acquisition or use of specialty pharmaceuticals that contains one of these (cannabis-derivative) substances.”
But individual marijuana-based medicines must still be approved by the National Medical Safety Agency.
How exactly the law will be implemented remains to be seen. That will be up to Minister Touraine, who will ratify the decree in coming weeks.
While the law appears to clear the way for marijuana-based medicines such as the sublingual spray Sativex and the old marijuana substitute Marinol (Cesamet), it could also allow for the use of raw marijuana produced under strict conditions for medical purposes, such as that produced by Bedrocan in the Netherlands.
But it co. . . . . READ MORE
Recent preclinical studies published over the past several weeks provide further evidence that cannabinoids are both neuroprotective and cardioprotective.
A May 30th blog post on the website Science20.com sums up new findings from Israel regarding the ability of low doses of THC to prevent brain damage in animals.
Prof. Yosef Sarne in the Department of Physiology and Pharmacology at Tel Aviv University says that [cannabis] … has neuroprotective qualities. He has found that extremely low doses of THC — the psychoactive component of marijuana — protects the brain from long-term cognitive damage in the wake of injury from hypoxia (lack of oxygen), seizures, or toxic drugs.
Previous studies focused on injecting high doses of THC within a very short time frame – approximately 30 minutes – before or after injury. Sarne’s papers in Behavioural Brain Research and Experimental Brain Research say that even extremely low doses of THC – around 1,000 to 10,000 times less than that in a conventional marijuana cigarette – administered over a wide window of 1 to 7 days before or 1 to 3 days after injury can jump-start biochemical processes which protect brain cells and preserve cognitive function over time.
… In the lab, the researchers injected mice with a single low dose of THC either before or after exposing them to brain trauma. A c. . . . . READ MORE
Recent preclinical studies published over the past several weeks provide further evidence that cannabinoids are both neuroprotective and cardioprotective.
A May 30th blog post on the website Science20.com sums up new findings from Israel regarding the ability of low doses of THC to prevent brain damage in animals.
Prof. Yosef Sarne in the Department of Physiology and Pharmacology at Tel Aviv University says that [cannabis] … has neuroprotective qualities. He has found that extremely low doses of THC — the psychoactive component of marijuana — protects the brain from long-term cognitive damage in the wake of injury from hypoxia (lack of oxygen), seizures, or toxic drugs.
Previous studies focused on injecting high doses of THC within a very short time frame – approximately 30 minutes – before or after injury. Sarne’s papers in Behavioural Brain Research and Experimental Brain Research say that even extremely low doses of THC – around 1,000 to 10,000 times less than that in a conventional marijuana cigarette – administered over a wide window of 1 to 7 days before or 1 to 3 days after injury can jump-start biochemical processes which protect brain cells and preserve cognitive function over time.
… In the lab, the researchers injected mice with a single low dose of THC either before or after exposing them to brain trauma. A c. . . . . READ MORE